THYRON PHARMACEUTICALS, INC.

Profile

Company Names

THYRON PHARMACEUTICALS, INC.

Addresses

4 DEEPWOOD LANE, WESTPORT, CT 06880

Phone Numbers

(203) 482-3123

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$500,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-04-20 
$500,000.00 
$1,000,000.00 
$500,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
BLOCH 
EXECUTIVE OFFICER, DIRECTOR
VIACOR INC   |  MARINUS PHARMACEUTICALS INC   |  LIQUIDIA TECHNOLOGIES INC   |  DICOM GRID INC   |  AXIAL EXCHANGE, INC.   |  ENVISIA THERAPEUTICS INC.   |  LQ3 PHARMACEUTICALS, INC.   |  ENVISIA THERAPEUTICS, INC.   |  SAMPLE6, INC.   |  GENOME MEDICAL HOLDING CO   |  CORVIUM, INC.   |  ONKOS SURGICAL, INC.   |  EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC   |  IANTREK, INC.   |  LIQUIDIA CORP   |  ALLYX THERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.
PETER 
 
FARINA 
DIRECTOR
THYRON PHARMACEUTICALS, INC.   |  REACTIVE BIOSCIENCES INC.
PAUL 
 
FONTEYNE 
EXECUTIVE OFFICER, DIRECTOR
DALCOR PHARMACEUTICALS US, LLC   |  ALLYX THERAPEUTICS, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  GELESIS HOLDINGS, INC.   |  APNIMED, INC.   |  TRITON THERAPEUTICS, INC.
DAVID 
 
SCHEER 
EXECUTIVE OFFICER, DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  TENGION INC   |  PLANIT IMPACT INC.   |  DNAMX, INC.   |  REFACTOR HEALTH, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  ADELA, INC.   |  THIRDLAW MOLECULAR, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-05-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#